1 / 3

Background

galvin-hoffman
Download Presentation

Background

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Towards a Science of Community Engagement in Biomedical HIV Prevention Trials: An Embedded Multiple Case Study in Canada, India, South Africa and ThailandNewman PA, Rubincam CC, Chuang D-M, Lindegger G, Slack C, Chakrapani V, Shunmugam M, Tepjan S, Roungprakhon S, & Canadian HIV Vaccine Initiative Team Background • Community stakeholder engagement (SE) is foundational to fair & ethically conducted biomedical HIV prevention trials • Scant empirical research has addressed SE • To identify cross-cutting & site specific challenges & facilitators of SE in global HIV prevention trials Methods • From 2009-2012 we conducted an embedded exploratory case study with a multiple case design (n=235)

  2. Multiple Case Study Design • Ensuring trial literacy • Addressing mistrust • Processes of meaningfulstakeholder engagement • Bangkok, Thailand • Chennai, India • Durban, S. Africa • Toronto, Canada Subsystems New Conception of Cases Cases CSO representatives Community leaders & advocates Community members Former trial participants Service providers Clinical trialists Decomposition Synthesis

  3. Conclusions • Trial literacy: Ensure understanding among community stakeholders of complex trial concepts • Historically-based mistrust among local communities • Ethical integrity: explore how trials can best meet ethical obligations (e.g. ancillary services, post-trial care) • Clear & transparent communication between researchers & trial participants • Autonomy & independent decision-makingof CABs/CBOs must be balanced with need for training & support

More Related